Literature DB >> 18693144

Intestinally derived lipids: metabolic regulation and consequences--an overview.

Katherine Cianflone1, Sabina Paglialunga, Christian Roy.   

Abstract

Various dietary factors affect postprandial metabolism yet precise mechanisms have not necessarily been pinpointed. The effects of various meal components on postprandial lipemia lead to the following question: do we need a standardized oral lipid tolerance test? A number of transporters, enzymes, receptors and hormones directly influence and act as "gatekeepers" of these processes. Each protein appears to have specific and individual functional roles in the overall process and selected developments in these areas will be reviewed. Within the intestinal cells, FABP2 (fatty acid-binding protein 2) and MTP (microsomal triglyceride transfer protein) are required for the formation of chylomicrons. Niemann-Pick C1-like 1 (NPC1-L1) plays an important role in cholesterol absorption and provides a pharmacological target. Hormones such as GLP1 and GLP2 influence this absorption process. Within the periphery, lipoprotein lipase (LPL) is a key gatekeeper of clearance. Of the massive amounts of fatty acids released by LPL, 36% escape peripheral adipose and muscle uptake and fatty acid overload can result in LPL product inhibition. Acylation stimulating protein (ASP) and insulin are two key hormones in maintaining efficient tissue uptake and re-esterification of fatty acids while TNFalpha negatively influences this process. In both ASP deficient (C3 KO) and C5L2 KO mice, postprandial lipemia increased with reduced adipose tissue storage. This is compensated by increased energy expenditure and muscle lipid oxidation. Clearance of hepatic remnants is controlled through many factors, including SR-B1 and ABCA1. Intestinal, peripheral and hepatic gatekeepers serve important and individual roles in regulating postprandial lipemia and provide potential targets for regulation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18693144     DOI: 10.1016/j.atherosclerosissup.2008.05.014

Source DB:  PubMed          Journal:  Atheroscler Suppl        ISSN: 1567-5688            Impact factor:   3.235


  12 in total

1.  ABCA1 gene variants regulate postprandial lipid metabolism in healthy men.

Authors:  Javier Delgado-Lista; Pablo Perez-Martinez; Francisco Perez-Jimenez; Antonio Garcia-Rios; Francisco Fuentes; Carmen Marin; Purificación Gómez-Luna; Antonio Camargo; Laurence D Parnell; Jose Maria Ordovas; Jose Lopez-Miranda
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-02-25       Impact factor: 8.311

2.  Ezetimibe ameliorates intestinal chylomicron overproduction and improves glucose tolerance in a diet-induced hamster model of insulin resistance.

Authors:  Mark Naples; Chris Baker; Marsel Lino; Jahangir Iqbal; M Mahmood Hussain; Khosrow Adeli
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-02-16       Impact factor: 4.052

3.  Postprandial changes in high density lipoproteins in rats subjected to gavage administration of virgin olive oil.

Authors:  Roberto Martínez-Beamonte; María A Navarro; Sergio Acin; Natalia Guillén; Cristina Barranquero; Carmen Arnal; Joaquín Surra; Jesus Osada
Journal:  PLoS One       Date:  2013-01-29       Impact factor: 3.240

4.  Chronic exposure to rifaximin causes hepatic steatosis in pregnane X receptor-humanized mice.

Authors:  Jie Cheng; Kristopher W Krausz; Naoki Tanaka; Frank J Gonzalez
Journal:  Toxicol Sci       Date:  2012-07-12       Impact factor: 4.849

5.  Plasma metabolomics and proteomics profiling after a postprandial challenge reveal subtle diet effects on human metabolic status.

Authors:  Linette Pellis; Marjan J van Erk; Ben van Ommen; Gertruud C M Bakker; Henk F J Hendriks; Nicole H P Cnubben; Robert Kleemann; Eugene P van Someren; Ivana Bobeldijk; Carina M Rubingh; Suzan Wopereis
Journal:  Metabolomics       Date:  2011-05-28       Impact factor: 4.290

6.  A preliminary report on oral fat tolerance test in rhesus monkeys.

Authors:  Di Wu; Qingsu Liu; Shiyuan Wei; Yu Alex Zhang; Feng Yue
Journal:  Lipids Health Dis       Date:  2014-01-10       Impact factor: 3.876

Review 7.  Pathophysiology of diabetic dyslipidaemia: where are we?

Authors:  Bruno Vergès
Journal:  Diabetologia       Date:  2015-03-01       Impact factor: 10.122

8.  Hypertriglyceridemia and Other Plasma Lipid Profile Abnormalities among People Living with Diabetes Mellitus in Ethiopia: A Systematic Review and Meta-Analysis.

Authors:  Baye Dagnew; Yigizie Yeshaw; Demeke Geremew; Dessie Abebaw Angaw; Henok Dagne; Mekuriaw Alemayehu; Meseret Derbew Molla; Yonas Akalu
Journal:  Biomed Res Int       Date:  2021-05-10       Impact factor: 3.411

9.  Serum Lipids and the Risk of Gastrointestinal Malignancies in the Swedish AMORIS Study.

Authors:  Wahyu Wulaningsih; Hans Garmo; Lars Holmberg; Niklas Hammar; Ingmar Jungner; Göran Walldius; Mieke Van Hemelrijck
Journal:  J Cancer Epidemiol       Date:  2012-08-30

10.  Liraglutide suppresses non-esterified free fatty acids and soluble vascular cell adhesion molecule-1 compared with metformin in patients with recent-onset type 2 diabetes.

Authors:  Xiao-Min Chen; Wen-Qiang Zhang; Yuan Tian; Li-Fen Wang; Chan-Chan Chen; Chuan-Mei Qiu
Journal:  Cardiovasc Diabetol       Date:  2018-04-10       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.